circ0005654 expedites the GC development via miR-363/sp1/myc/Wnt/beta-catenin axis and is a new biomarker for GC treatment regimen.
The circular RNA circ0005654 interacts with specificity protein 1 via microRNA-363 sequestration to promote gastric cancer progression.